Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-08-10
2011-12-20
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S563000
Reexamination Certificate
active
08080548
ABSTRACT:
The present embodiments are related to the compound of Formula 1 or Formula 2 below and pharmaceutical formulations thereof as well as treatments for a wide variety of Central Nervous System disorders with the pharmaceutical formulations. Some embodiments include the use of a variety of the instant compounds which surprisingly and advantageously exhibit improved pharmacokinetic and therapeutic profiles in comparison to pivagabine.
REFERENCES:
patent: 2003/0176398 (2003-09-01), Gallop et al.
patent: 2005/0009814 (2005-01-01), Iwayama et al.
patent: WO98/38988 (1998-09-01), None
Gary Stix, Science American, p. 51-57 (Jun. 2010).
Gerra et al., Behavioural Brain Research, V122 (2001), p. 93-101.
Boussard et al., Bioploymers, 1977, 16(5), pp. 1033-1052, Abstract.
Cenerx Biopharma, Inc.
Chu Yong
Womble Carlyle Sandridge & Rice LLP
LandOfFree
Dialkylamino alkyl esters of pivagabine as medicaments for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dialkylamino alkyl esters of pivagabine as medicaments for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dialkylamino alkyl esters of pivagabine as medicaments for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4303227